PharmaMar signs a license agreement for Aplidin® with Megapharm in Israel

(Pharmamar) PharmaMar (MSE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin® (plitidepsin) in Israel and the territory known as the Palestinian Authority.